These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19698169)

  • 1. Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario.
    Choi YH; Cotterchio M; McKeown-Eyssen G; Neerav M; Bapat B; Boyd K; Gallinger S; McLaughlin J; Aronson M; Briollais L
    Hered Cancer Clin Pract; 2009 Aug; 7(1):14. PubMed ID: 19698169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
    Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
    JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
    Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
    Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence.
    Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K
    Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
    Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
    Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.
    Stoffel E; Mukherjee B; Raymond VM; Tayob N; Kastrinos F; Sparr J; Wang F; Bandipalliam P; Syngal S; Gruber SB
    Gastroenterology; 2009 Nov; 137(5):1621-7. PubMed ID: 19622357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
    Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT
    J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management.
    Ramsoekh D; Wagner A; van Leerdam ME; Dooijes D; Tops CM; Steyerberg EW; Kuipers EJ
    Hered Cancer Clin Pract; 2009 Dec; 7(1):17. PubMed ID: 20028567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in
    Dominguez-Valentin M; Plazzer JP; Sampson JR; Engel C; Aretz S; Jenkins MA; Sunde L; Bernstein I; Capella G; Balaguer F; Macrae F; Winship IM; Thomas H; Evans DG; Burn J; Greenblatt M; de Vos Tot Nederveen Cappel WH; Sijmons RH; Nielsen M; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Lindblom A; Valle AD; Lopez-Kostner F; Alvarez K; Gluck N; Katz L; Heinimann K; Vaccaro CA; Nakken S; Hovig E; Green K; Lalloo F; Hill J; Vasen HFA; Perne C; Büttner R; Görgens H; Holinski-Feder E; Morak M; Holzapfel S; Hüneburg R; von Knebel Doeberitz M; Loeffler M; Rahner N; Weitz J; Steinke-Lange V; Schmiegel W; Vangala D; Crosbie EJ; Pineda M; Navarro M; Brunet J; Moreira L; Sánchez A; Serra-Burriel M; Mints M; Kariv R; Rosner G; Piñero TA; Pavicic WH; Kalfayan P; Broeke SWT; Mecklin JP; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Peltomäki P; Hopper JL; Win AK; Buchanan DD; Lindor NM; Gallinger S; Marchand LL; Newcomb PA; Figueiredo JC; Thibodeau SN; Therkildsen C; Hansen TVO; Lindberg L; Rødland EA; Neffa F; Esperon P; Tjandra D; Möslein G; Seppälä TT; Møller P
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34203177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
    Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
    J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.
    van der Post RS; Kiemeney LA; Ligtenberg MJ; Witjes JA; Hulsbergen-van de Kaa CA; Bodmer D; Schaap L; Kets CM; van Krieken JH; Hoogerbrugge N
    J Med Genet; 2010 Jul; 47(7):464-70. PubMed ID: 20591884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers.
    Olschwang S; Yu K; Lasset C; Baert-Desurmont S; Buisine MP; Wang Q; Hutter P; Rouleau E; Caron O; Bourdon V; Thomas G
    J Cancer Epidemiol; 2009; 2009():791754. PubMed ID: 20445804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetrance of Colorectal Cancer Among Mismatch Repair Gene Mutation Carriers: A Meta-Analysis.
    Wang C; Wang Y; Hughes KS; Parmigiani G; Braun D
    JNCI Cancer Spectr; 2020 Aug; 4(5):pkaa027. PubMed ID: 32923933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models.
    Kopciuk KA; Choi YH; Parkhomenko E; Parfrey P; McLaughlin J; Green J; Briollais L
    Hered Cancer Clin Pract; 2009 Oct; 7(1):16. PubMed ID: 19863818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States.
    Kastrinos F; Stoffel EM; Balmaña J; Steyerberg EW; Mercado R; Syngal S
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2044-51. PubMed ID: 18708397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome.
    Win AK; Clendenning M; Crawford W; Rosty C; Preston SG; Southey MC; Parry S; Giles GG; Macrae FA; Winship IM; Baron JA; Hopper JL; Jenkins MA; Buchanan DD
    Genes Cancer; 2015 Nov; 6(11-12):445-51. PubMed ID: 26807197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium.
    Møller P; Seppälä T; Dowty JG; Haupt S; Dominguez-Valentin M; Sunde L; Bernstein I; Engel C; Aretz S; Nielsen M; Capella G; Evans DG; Burn J; Holinski-Feder E; Bertario L; Bonanni B; Lindblom A; Levi Z; Macrae F; Winship I; Plazzer JP; Sijmons R; Laghi L; Valle AD; Heinimann K; Half E; Lopez-Koestner F; Alvarez-Valenzuela K; Scott RJ; Katz L; Laish I; Vainer E; Vaccaro CA; Carraro DM; Gluck N; Abu-Freha N; Stakelum A; Kennelly R; Winter D; Rossi BM; Greenblatt M; Bohorquez M; Sheth H; Tibiletti MG; Lino-Silva LS; Horisberger K; Portenkirchner C; Nascimento I; Rossi NT; da Silva LA; Thomas H; Zaránd A; Mecklin JP; Pylvänäinen K; Renkonen-Sinisalo L; Lepisto A; Peltomäki P; Therkildsen C; Lindberg LJ; Thorlacius-Ussing O; von Knebel Doeberitz M; Loeffler M; Rahner N; Steinke-Lange V; Schmiegel W; Vangala D; Perne C; Hüneburg R; de Vargas AF; Latchford A; Gerdes AM; Backman AS; Guillén-Ponce C; Snyder C; Lautrup CK; Amor D; Palmero E; Stoffel E; Duijkers F; Hall MJ; Hampel H; Williams H; Okkels H; Lubiński J; Reece J; Ngeow J; Guillem JG; Arnold J; Wadt K; Monahan K; Senter L; Rasmussen LJ; van Hest LP; Ricciardiello L; Kohonen-Corish MRJ; Ligtenberg MJL; Southey M; Aronson M; Zahary MN; Samadder NJ; Poplawski N; Hoogerbrugge N; Morrison PJ; James P; Lee G; Chen-Shtoyerman R; Ankathil R; Pai R; Ward R; Parry S; Dębniak T; John T; van Overeem Hansen T; Caldés T; Yamaguchi T; Barca-Tierno V; Garre P; Cavestro GM; Weitz J; Redler S; Büttner R; Heuveline V; Hopper JL; Win AK; Lindor N; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo J; Buchanan DD; Thibodeau SN; Ten Broeke SW; Hovig E; Nakken S; Pineda M; Dueñas N; Brunet J; Green K; Lalloo F; Newton K; Crosbie EJ; Mints M; Tjandra D; Neffa F; Esperon P; Kariv R; Rosner G; Pavicic WH; Kalfayan P; Torrezan GT; Bassaneze T; Martin C; Moslein G; Ahadova A; Kloor M; Sampson JR; Jenkins MA;
    Hered Cancer Clin Pract; 2022 Oct; 20(1):36. PubMed ID: 36182917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).
    Geary J; Sasieni P; Houlston R; Izatt L; Eeles R; Payne SJ; Fisher S; Hodgson SV
    Fam Cancer; 2008; 7(2):163-72. PubMed ID: 17939062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.